Pipeline dossier

NIH & clinical-trial pipeline signals for NOVARTIS AG (NVS)

Leading indicators across the NIH grant → clinical trial → SEC filing chain for NVS, mapped to public ticker NVS (CIK 0001114448). Sourced live from public data.

⚠ Research/informational signals from public data (NIH · ClinicalTrials.gov · SEC EDGAR). Not investment advice. Full scope →

Trial → FilingNVS35% conf

NOVARTIS AG (NVS) — PHASE2 protocol updated 13 days ago

Upstream (observed)
Clinical trial status (PHASE2) — A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

↓ Phase-transition base rate 28% (Wong/Siah/Lo 2019)

Predicted downstream
SEC 8-K / press release on Phase 3 initiation (18-36 mo, base rate 28%)

trial ↗filings ↗

JSON API for this entity →